PHG

Koninklijke Philips
D

PHG

Arincen44/100B

Koninklijke Philips return on equity (ROE)

Koninklijke Philips's return on equity is 8.18%: net income of 963.31M EUR over the last twelve months on shareholders' equity of 11.78B EUR.

Today
8.18%
Average, 5 years
1.91%
Low, 5 years
-16.72%
High, 5 years
22.99%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 963.31M ÷ 11.78B = 8.18%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

What drives Koninklijke Philips's return on equity?

Net margin
5.0%
profit on each dollar of sales
Asset turnover
0.66×
sales on each dollar of assets
Equity multiplier
2.46×
assets on each dollar of equity
Return on equity
8.2%
FY2025
  • FY20255.0% × 0.66 × 2.46 = 8.2%
  • FY2024-3.9% × 0.62 × 2.41 = -5.8%
  • FY2023-2.6% × 0.62 × 2.44 = -3.9%
  • FY2022-9.0% × 0.58 × 2.32 = -12.1%
  • FY202119.3% × 0.55 × 2.14 = 23.0%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today8.18%963.31M11.78B
FY202531 Dec 20258.17%895.00M10.96B
FY202431 Dec 2024-7.60%-912.95M12.01B
FY202331 Dec 2023-4.10%-492.99M12.03B
FY202231 Dec 2022-12.86%-1.70B13.25B
FY202131 Dec 20214.98%718.64M14.44B
FY202031 Dec 202010.00%1.19B11.87B
FY201931 Dec 201910.54%1.33B12.60B
FY201831 Dec 201810.84%1.31B12.09B
FY201731 Dec 20178.56%1.03B12.00B
FY201631 Dec 20168.53%1.08B12.60B
FY201531 Dec 20153.55%414.00M11.66B
FY201431 Dec 20142.03%221.00M10.87B
FY201331 Dec 201310.43%1.17B11.21B
FY201231 Dec 20122.35%262.00M11.14B
FY201131 Dec 2011-6.28%-776.00M12.36B
FY201031 Dec 20109.65%1.45B15.05B
FY200931 Dec 20092.81%410.00M14.60B
FY200831 Dec 20080.05%8.00M15.59B
FY200731 Dec 200719.22%4.17B21.72B
FY200631 Dec 200623.41%5.38B23.00B
FY200531 Dec 200517.71%2.95B16.65B
FY200431 Dec 200419.09%2.83B14.85B
FY200331 Dec 20035.45%693.98M12.74B
FY200231 Dec 2002-23.03%-3.21B13.93B
FY200131 Dec 2001-14.11%-2.61B18.48B
FY200031 Dec 200044.17%9.63B21.80B
FY199931 Dec 199912.19%1.80B14.80B
FY199831 Dec 199842.63%6.02B14.12B
FY199731 Dec 199729.47%2.57B8.73B
FY199631 Dec 1996-4.23%-272.38M6.44B
FY199531 Dec 199519.10%1.30B6.82B
FY199431 Dec 199414.72%998.29M6.78B
FY199331 Dec 199315.05%906.61M6.03B
FY199231 Dec 1992-9.92%-409.39M4.13B
FY199131 Dec 19917.42%429.36M5.79B
FY199031 Dec 1990-34.24%-1.96B5.72B
FY198931 Dec 19894.14%349.71M8.44B
FY198831 Dec 19883.21%226.48M7.05B
FY198731 Dec 19873.47%234.64M6.75B

Figures in EUR. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Debt to equity,Current ratio,All ratios

Common questions about Koninklijke Philips's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.